信达国际港股晨报快-20250822

Market Overview - The Hang Seng Index is expected to challenge the 26,000 point mark, supported by stable economic performance in mainland China and a positive risk appetite in the market [2][5] - The US Federal Reserve's recent stance on interest rates and trade negotiations with multiple countries are contributing to a more favorable market environment [3][6] Sector Outlook - The biopharmaceutical sector is showing strong performance, with increased support from the mainland government [6] - The electric vehicle sector is experiencing a surge in new vehicle releases, with some companies raising their annual sales targets, indicating confidence in the market [6] Company Performance - Li Ning (2331) reported a mid-term profit of 1.74 billion, a decrease of 10%, but better than expected [3] - Kuaishou (1024) saw a 20% increase in profit and a 13% rise in revenue, surpassing expectations and declaring a special dividend of 0.46 yuan [3] - Bilibili (9626) turned a profit of 560 million in the second quarter, exceeding expectations [3] - AAC Technologies (2018) reported a 63% increase in mid-term net profit, although the gross margin was below expectations [3] - Miniso (9896) experienced a 23% drop in mid-term profit, yet still beat expectations and declared a special dividend [3] - The Fourth Paradigm (6682) reported a 40.7% increase in revenue for the first half of the year, with losses narrowing to 66.97 million yuan [9] - Xpeng Motors (9868) saw its chairman increase holdings by purchasing 3.1 million shares [9] Economic Indicators - China's total electricity consumption surpassed 1 trillion kilowatt-hours in July, marking a significant milestone and reflecting robust industrial production [7] - Hong Kong's Consumer Price Index (CPI) rose by 1% in July, higher than expected, indicating controlled inflationary pressures [7] - The US housing market showed a 2% increase in existing home sales in July, with the median home price rising by 0.2%, the smallest increase in two years [8]